CIK: 0002013341
Total reported value
$460.3M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | CGON | Cg Oncology INC | Stock-Other | 27.88% | +4.79% | — | |
| 2 | RAPT | Rapt Therapeutics INC | Stock-Other | 16.00% | -16.00% | EXIT | |
| 3 | ALMS | Alumis INC | Stock-Other | 12.53% | +7.80% | — | |
| 4 | 260 | Centessa Pharmaceuticals-adr | Stock-Other | 10.31% | +1.46% | +3.81% | |
| 5 | VSTM | Verastem INC | Stock-Other | 7.32% | -3.70% | +19.88% | |
| 6 | DNLI | Denali Therapeutics INC | Stock-Other | 4.99% | +0.06% | — | |
| 7 | NTRA | Natera INC | Stock-Healthcare | 4.66% | -4.66% | EXIT | |
| 8 | AGIO | Agios Pharmaceuticals INC | Stock-Other | 4.36% | -0.50% | — | |
| 9 | KYMR | Kymera Therapeutics INC | Stock-Other | 3.44% | -0.79% | — | |
| 10 | ATAI | AtaiBeckley Inc. | Stock-Other | 3.40% | -3.40% | EXIT | |
| 11 | CRVS | Corvus Pharmaceuticals INC | Stock-Other | 3.21% | +2.61% | -20.22% | |
| 12 | HNGE | Hinge Health Inc-a | Stock-Other | 1.90% | -0.05% | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ALMS | Alumis INC | +6% | — | Unchanged |
| 2 | RAPT | Rapt Therapeutics INC | +0.4% | — | Unchanged |
| 3 | KYMR | Kymera Therapeutics INC | +0.2% | — | Unchanged |
| 4 | DNLI | Denali Therapeutics INC | -0.6% | — | Unchanged |
| 5 | HNGE | Hinge Health Inc-a | -0.7% | — | Unchanged |
| 6 | VSTM | Verastem INC | -1.6% | +19.88% | Add |
| 7 | CRVS | Corvus Pharmaceuticals INC | -1.7% | -20.22% | Trim |
| 8 | 260 | Centessa Pharmaceuticals-adr | -2% | +3.81% | Add |
| 9 | CGON | Cg Oncology INC | -6.7% | — | Unchanged |
| 10 | NTRA | Natera INC | — | NEW | New buy |
| 11 | AGIO | Agios Pharmaceuticals INC | — | NEW | New buy |
| 12 | AKRO | Akero Therapeutics INC | — | EXIT | Sold out |
| 13 | ATAI | AtaiBeckley Inc. | — | NEW | New buy |
| 14 | RNAGBP | Avidity Biosciences INC | — | EXIT | Sold out |
| 15 | ✓ | Casi Pharmaceuticals INC | — | EXIT | Sold out |